Acquired Ocular Toxoplasmosis in Pregnancy
August 2002
in “
British Journal of Ophthalmology
”
Studysummary This case study reports that intralesional cidofovir was successfully used for treatment without systemic toxicity, suggesting it might be an option worth considering for SCC. Our plain-language summary of this paper — not a Tressless recommendation.
The document discussed various side effects of treatments, including kidney toxicity, uveitis, macular oedema, neutropenia, thrombocytopenia, nausea, fever, hair loss, and muscle pain. It noted that topical or intralesional administration of cidofovir had not shown systemic toxicity. Surgical excision was highlighted as the best treatment for SCC due to its curative potential and ability to allow histopathological evaluation of margins. However, the document suggested that the successful outcome with intralesional cidofovir in a specific case might be worth considering as an alternative treatment.